Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough

Moderna and Merck have achieved a significant breakthrough in cancer vaccine development after a century of failures. Cancer experts describe this advancement as the start of a new era featuring custom-made vaccines. These innovative treatments are designed to train the immune system to specifically target and fight an individual patient's cancer. This personalized approach marks a pivotal shift in oncology, offering a tailored method to combat the disease by leveraging the body's own natural defenses.